• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - Fluorescent Protein
Tag:

Fluorescent Protein

Health

Using blood proteins to make living brains transparent

by Chief Editor March 13, 2026
written by Chief Editor

Seeing Through the Brain: A New Era of Live Imaging

For decades, scientists have dreamed of observing the intricate workings of a living brain without disrupting its delicate functions. Now, that vision is becoming a reality, thanks to a groundbreaking reagent called SeeDB-Live, developed by researchers at Kyushu University. This innovation promises to revolutionize our understanding of neurological processes and accelerate advancements in brain research.

The Challenge of Brain Transparency

The brain’s opacity has long been a major obstacle to studying its inner workings. Light scatters when traveling through brain tissue due to differences in refractive indices between its components – lipids, cells, and fluids. This scattering obscures deeper structures, making it hard to visualize neuronal activity. Researchers have previously attempted to address this by clearing tissue, but these methods often compromised the living cells’ functionality.

From Marbles to Neurons: The Optics Behind the Breakthrough

The principle behind SeeDB-Live is rooted in optics. Just as a glass marble becomes nearly invisible in oil due to matching refractive indices, the reagent aims to minimize light scattering within the brain. The team discovered that achieving a refractive index of 1.36–1.37 is key to maximizing transparency in living cells.

Albumin: The Unexpected Key

The search for a non-toxic solution to adjust the refractive index while maintaining osmotic balance proved challenging. Previous attempts using substances like sugar resulted in cellular dehydration. The breakthrough came unexpectedly when Assistant Professor Shigenori Inagaki revisited the basic properties of polymers. He tested bovine serum albumin (BSA), a common blood protein, and found it possessed the ideal characteristics – large size for minimal osmotic pressure and the ability to achieve the target refractive index.

“I tested it three or four times before I believed it,” Inagaki recalled. The reagent, SeeDB-Live, renders mouse brain slices transparent within an hour and increases fluorescence signals from deep neurons threefold in living mouse brains.

Unlocking Deeper Insights into Brain Function

SeeDB-Live allows scientists to observe neuronal activity in previously inaccessible areas, such as layer 5 of the cerebral cortex, crucial for information processing and translating neural activity into action. Importantly, the method is reversible; the tissue returns to its original state as the reagent washes away, enabling repeated imaging of the same brain over time.

Potential Applications Beyond Basic Research

The implications of this technology extend beyond fundamental neuroscience. Researchers anticipate SeeDB-Live will enhance deep fluorescence imaging, aiding in the understanding of brain integrative functions. It too holds promise for evaluating 3D tissues and brain organoids in drug discovery research.

Future Directions and Challenges

While SeeDB-Live represents a significant leap forward, challenges remain. Delivering the reagent to organs beyond the brain is limited by biological barriers. Accessing the brain itself still requires a surgical window, which can introduce stress and reduce efficiency. Future research will focus on less invasive delivery methods to improve penetration and functional analysis.

Senior author Takeshi Imai, reflecting on a decade of work, notes, “I feel we have not yet fully materialized its potential.”

FAQ

Q: What is SeeDB-Live?
A: SeeDB-Live is a new reagent that uses albumin, a blood protein, to create living brain tissue transparent for imaging.

Q: How does SeeDB-Live work?
A: It adjusts the refractive index of the fluid surrounding brain cells, reducing light scattering and allowing for deeper, clearer imaging.

Q: Is SeeDB-Live harmful to brain cells?
A: No, SeeDB-Live is designed to be minimally invasive and does not cause permanent changes to the tissue.

Q: What are the potential applications of this technology?
A: It can be used to study brain function, evaluate drug candidates, and improve our understanding of neurological disorders.

Did you realize? Albumin, the key ingredient in SeeDB-Live, is naturally abundant in blood, making it a readily available and biocompatible reagent.

Pro Tip: The success of SeeDB-Live highlights the importance of revisiting fundamental principles and exploring unexpected solutions in scientific research.

Want to learn more about the latest advancements in neuroscience? Explore our other articles on brain imaging techniques and neurological research.

Stay updated with the latest breakthroughs in science – subscribe to our newsletter today!

March 13, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Lab-grown corticospinal neurons offer new models for ALS and spinal injuries

by Chief Editor January 30, 2026
written by Chief Editor

Breakthrough in Brain Cell Research Offers Hope for ALS and Spinal Injury Treatment

A team of researchers at Harvard University has achieved a significant milestone in regenerative medicine: successfully growing highly specialized brain nerve cells crucial for motor function. This breakthrough, published in eLife, focuses on corticospinal neurons – cells severely impacted in conditions like Amyotrophic Lateral Sclerosis (ALS) and spinal cord injuries. The ability to reliably generate these cells in a lab setting opens exciting new avenues for disease modeling and potential therapies.

The Challenge of Specialized Neurons

The nervous system is incredibly complex, comprised of diverse neuron types each with unique roles. Creating these specific subtypes in a lab has been a major hurdle. “Generic or regionally similar neurons do not adequately reflect the selective vulnerability of neuron subtypes in most human neurodegenerative diseases or injuries,” explains Kadir Ozkan, a co-lead author of the study. Simply put, understanding and treating these diseases requires working with the *right* kind of brain cells.

Currently, there are limited in vitro (lab-based) models to study the specific degeneration of corticospinal neurons in ALS or to explore regeneration strategies for spinal cord injuries. This lack of accurate models has significantly hampered research progress. ALS, for example, affects over 30,000 Americans, with a median survival time of 2-5 years after diagnosis, highlighting the urgent need for effective treatments.

Unlocking the Potential of Cortical Progenitors

The Harvard team focused on a specific type of brain stem cell called cortical progenitors – cells that can develop into various types of neurons. They identified a subset of these progenitors, marked by the presence of proteins Sox6 and NG2 (Sox6+/NG2+ cells), that showed a remarkable ability to be “reprogrammed” into corticospinal neurons. This discovery builds on previous work identifying the molecular programs that control neuron development.

Pro Tip: Stem cell research is rapidly evolving. Understanding the concept of ‘directed differentiation’ – guiding stem cells to become specific cell types – is key to grasping the potential of this field.

To achieve this precise reprogramming, the researchers developed a sophisticated system called “NVOF” – a multi-component gene-expression system. NVOF fine-tunes the signals received by the progenitor cells, directing them down a specific developmental pathway. The results were striking: the reprogrammed cells exhibited the same shape, molecular markers, and electrical activity as naturally occurring corticospinal neurons. In contrast, a common alternative method yielded cells with abnormal characteristics.

Future Trends and Therapeutic Implications

While this research is currently limited to lab-grown cells, the implications are profound. Here are some potential future trends:

  • Personalized Medicine: Researchers could potentially use a patient’s own cells to generate corticospinal neurons, creating a personalized model to test drug efficacy and tailor treatment plans.
  • Drug Discovery: The new in vitro model will accelerate the screening of potential drug candidates for ALS and spinal cord injury, identifying compounds that protect or regenerate corticospinal neurons.
  • Regenerative Therapies: The ultimate goal is to transplant these lab-grown neurons into patients to replace damaged cells and restore function. The fact that Sox6+/NG2+ progenitor cells are readily available within the brain itself offers a significant advantage.
  • Advanced Bioengineering: Combining this cell differentiation technique with bioengineering approaches, such as scaffold creation and growth factor delivery, could enhance neuron survival and integration after transplantation.

Recent advancements in gene editing technologies, like CRISPR-Cas9, could further refine the reprogramming process, increasing the efficiency and precision of corticospinal neuron generation. Furthermore, the integration of artificial intelligence (AI) and machine learning algorithms could help identify novel molecular targets for promoting neuron survival and regeneration.

Did you know? Spinal cord injuries affect approximately 17,900 new people each year in the United States, according to the National Spinal Cord Injury Association.

Challenges and Next Steps

The eLife editors acknowledge that this study is an important first step, but further research is crucial. The next phase involves testing how these reprogrammed neurons function within a living organism. Researchers need to determine if they can successfully integrate into the nervous system, form functional connections, and restore lost function in models of ALS and spinal cord injury.

The team also plans to explore the use of human pluripotent stem cells – cells that can differentiate into any cell type in the body – to generate even larger quantities of corticospinal neurons for research and potential therapeutic applications.

Frequently Asked Questions (FAQ)

Q: What is ALS?
A: Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and eventually death.

Q: What are corticospinal neurons?
A: These are crucial nerve cells that transmit signals from the brain to the spinal cord, controlling voluntary movement.

Q: Is this a cure for ALS or spinal cord injury?
A: No, this is a significant research breakthrough, but it’s still early stages. More research is needed to determine if these lab-grown neurons can effectively treat these conditions.

Q: What are progenitor cells?
A: Progenitor cells are immature cells that have the potential to develop into specific cell types, like neurons.

This research represents a beacon of hope for individuals affected by devastating neurological conditions. By unlocking the secrets of corticospinal neuron development, scientists are paving the way for innovative therapies that could one day restore movement and improve the lives of millions.

Want to learn more? Explore our articles on Neurodegenerative Diseases and Spinal Cord Injury.

January 30, 2026 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Should Man Utd Appoint Michael Carrick Now?

    May 3, 2026
  • Repurposed drug offers hope for one of the world’s rarest diseases

    May 3, 2026
  • Spider and horseshoe crab relatives emerged 20 million years earlier than scientists thought

    May 3, 2026
  • Viral Video: Deer Spotted Swimming in Lake Balaton

    May 3, 2026
  • Sinn Féin says Bobby Sands statue ‘is going nowhere’ at anniversary event

    May 3, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World